Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate Safety and Efficacy of KPI-012 Ophthalmic Solution in Participants With Persistent Corneal Epithelial Defect (PCED)

NCT05727878 is registered in ClinicalTrials.gov with Combangio, Inc as lead sponsor.

NCT NCT05727878
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05727878 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate Safety and Efficacy of KPI-012 Ophthalmic Solution in Participants With Persistent Corneal Epithelial Defect (PCED)
Lead sponsor
Combangio, Inc
Phase
Phase 2
Overall status
Terminated
Start date
February 7, 2023
Completion date
October 19, 2025
Enrollment
103 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

persistent corneal epithelial defect